CD Access is a nonprofit organization based in Newport Beach, CA, that offers a unique approach to providing therapeutic access to patients. Through their innovative model, they enable patients to access drugs and therapies that are currently unavailable through clinical trials or prescription.
One of CD Access' notable programs focuses on Duchenne muscular dystrophy patients in Canada who have previously participated in a clinical trial for drisapersen. By collaborating with BioMarin, CD Access facilitates the redosing of this exon 51 skipping drug through the Health Canada Special Access Programme, ensuring eligible patients receive the necessary treatment at designated healthcare facilities.
Generated from the website